Jeffrey Lancet, MD, is a Senior Member and Chair of the Department of Malignant Hematology for the H Lee Moffitt Cancer Center and Research Institute in Tampa, Florida. He is a hematologist and focuses his clinical practice in acute leukemias and myelodysplastic syndromes. He also provides consultation for other hematologic malignancies. As a clinical investigator, Dr Lancet has written, authored, and published several early phase clinical trials utilizing novel therapies for these diseases, and currently serves as the principal investigator for many ongoing trials. Within the field of acute leukemias, he has worked extensively with the National Cancer Institute (NCI) and the Southwest Oncology Group. Dr Lancet was a recipient of the NCI-ASCO Clinical Investigator Team Leadership Award in 2010.